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abstract
 
A deﬁning property of L-type Ca
 
2
 
 
 
 channels is their potentiation by both 1,4-dihydropyridine ago-
nists and strong depolarization. In contrast, non–L-type channels are potentiated by neither agonist nor depolar-
ization, suggesting that these two processes may by linked. In this study, we have tested whether the mechanisms of
agonist- and depolarization-induced potentiation in the cardiac L-type channel (
 
 
 
1C
 
) are linked. We found that
the mutant L-type channel GFP-
 
 
 
1C
 
(TQ
 
→
 
YM), bearing the mutations T1066Y and Q1070M, was able to undergo
depolarization-induced potentiation but not potentiation by agonist. Conversely, the chimeric channel GFP-CACC
was potentiated by agonist but not by strong depolarization. These data indicate that the mechanisms of agonist-
and depolarization-induced potentiation of 
 
 
 
1C
 
 are distinct. Since neither GFP-CACC nor GFP-CCAA was potenti-
ated signiﬁcantly by depolarization, no single repeat of 
 
 
 
1C 
 
appears to be responsible for depolarization-induced
potentiation. Surprisingly, GFP-CACC displayed a low estimated open probability similar to that of the 
 
 
 
1C
 
, but
could not support depolarization-induced potentiation, demonstrating that a relatively low open probability alone
is not sufﬁcient for depolarization-induced potentiation to occur. Thus, depolarization-induced potentiation may
be a global channel property requiring participation from all four homologous repeats.
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INTRODUCTION
 
Voltage-gated Ca
 
2
 
 
 
 channels respond to membrane de-
polarization by allowing Ca
 
2
 
 
 
 into the cell, and, thus,
mediate a variety of cellular responses in neurons and
muscle, including transmitter release, neurite out-
growth, altered gene expression, exocytosis, and mus-
cle contraction (Reuter, 1983; Hoshi and Smith, 1987;
Tsien et al., 1988; Tanabe et al., 1993). Thus, modiﬁca-
tion of Ca
 
2
 
 
 
 inﬂux provides an important mechanism
for the regulation of many downstream Ca
 
2
 
 
 
-depen-
dent responses. One source of modiﬁcation is potentia-
tion, whereby a channel is stabilized in the open state,
and intracellular Ca
 
2
 
 
 
 levels are increased as a result.
L-type Ca
 
2
 
 
 
 channels show a shift in gating mode in
response to either strong depolarization or 1,4-dihydro-
pyridine (DHP)* agonist. After strong depolarization,
the channel enters a state of higher open probability
(P
 
o
 
) and long open times that can be detected by a
number of different pulse paradigms. For example, af-
ter a strong, conditioning depolarization (e.g., 
 
 
 
120
mV) followed by a 50–150-ms return to the holding po-
tential, a subsequent, moderate depolarization elicits a
Ca
 
2
 
 
 
 channel current that is about twofold larger than
that measured without the conditioning depolarization
(Bourinet et al., 1994; Cens et al., 1996, 1998). This ef-
fect, which implies an alteration of gating that persists
after channel closing, will be designated “depolariza-
tion-induced facilitation.” Both L- and non–L-type
channels are also able to undergo another form of
prepulse facilitation (“Ca
 
2
 
 
 
/CAM-dependent facilita-
tion”; Lee et al., 2000; Zühlke et al., 2000; DeMaria et
al., 2001), which differs from depolarization-induced
facilitation in that it has a bell-shaped dependence on
the prepulse potential that arises from a primary de-
pendence upon Ca
 
2
 
 
 
 entry. Ca
 
2
 
 
 
/CAM-dependent fa-
cilitation appears to depend speciﬁcally (Lee et al.,
2000) upon the 
 
 
 
2a
 
 subunit, and does not occur in cells
expressing 
 
 
 
1
 
, the isoform present in the dysgenic myo-
tubes used in our study. Unlike Ca
 
2
 
 
 
/CAM-dependent
facilitation, depolarization-induced facilitation may be
related to another form of altered gating observed
when a strong depolarization is followed immediately
by repolarization to an intermediate potential (Hoshi
and Smith, 1987; Pietrobon and Hess, 1990; Kleppisch
et al., 1994). This phenomenon, referred to here as de-
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polarization-induced potentiation, results in a mode of
gating characterized at the single-channel level by high
P
 
o
 
 and long open times, which is also referred to as
“mode 2” gating (Pietrobon and Hess, 1990). As an in-
dication of depolarization-induced entry into mode 2,
we have measured whole-cell tail currents upon repo-
larization to 
 
 
 
50 mV immediately after a strong, condi-
tioning depolarization. With this protocol, high P
 
o 
 
and
long open times are reﬂected by an increased tail-cur-
rent amplitude and slower rate of tail-current decay, re-
spectively. Mode 2 gating of L-type channels is also pro-
moted by DHP agonists (Hess et al., 1984; Nowycky et
al., 1985; Hoshi and Smith, 1987). Given the similari-
ties between agonist- and depolarization-induced po-
tentiation, it is important to know the degree to which
the two processes are related.
The cardiac L-type channel,
 
 
 
 
 
1C
 
, normally exhibits a
low P
 
o
 
 
 
 
 
 0.05 (Cachelin et al., 1983; Lew et al., 1991)
and can be potentiated by both strong depolarization
and DHP agonists. By contrast, the neuronal non–
L-type channel,
 
 
 
 
 
1A
 
, exhibits a high P
 
o
 
 of 
 
 
 
0.6 (Llinas
et al., 1989) and lacks both depolarization-induced
facilitation (Bourinet et al., 1994), and DHP-induced
potentiation (Sather et al., 1993). These observations
suggest the possibility that depolarization- and agonist-
induced potentiation can only occur in channels like
 
 
 
1C
 
 that have an intrinsically low P
 
o
 
.
In an attempt to determine whether potentiation of
 
 
 
1C
 
 by DHP agonist and strong depolarization occurs
via a common pathway, we have characterized wild-type
and mutant 
 
 
 
1C
 
 channels and chimeric channels com-
posed of 
 
 
 
1C
 
 and 
 
 
 
1A
 
 sequence. The channels were
fused at their amino termini to green ﬂuorescent
protein (GFP), expressed in dysgenic myotubes and
examined using whole-cell patch clamp. For an 
 
 
 
1C
 
 in
which the agonist binding site was mutated (GFP-
 
 
 
1C
 
(TQ
 
→
 
YM)), 10 
 
 
 
M Bay K 8644 had no signiﬁcant
effect on whole-cell currents, whereas depolarization-
induced potentiation remained intact. A chimeric
channel containing repeat II and the I-II linker of 
 
 
 
1A
 
sequence embedded in L-type background (GFP-
CACC) could not support depolarization-induced po-
tentiation but was potentiated by DHP agonist. Chan-
nels containing three (CACC), two (CCAA), or no
(
 
 
 
1A
 
) repeats of L-type sequence were not potentiated
signiﬁcantly by depolarization, suggesting that depolar-
ization-induced potentiation cannot be localized to any
single channel repeat. Interestingly, despite having a
relatively low estimated P
 
o
 
 comparable to that of 
 
 
 
1C
 
,
GFP-CACC was not potentiated by depolarization, indi-
cating that depolarization-induced potentiation must
not be dependent solely on a low P
 
o
 
. Our results dem-
onstrate that the mechanisms of DHP agonist- and de-
polarization-induced potentiation of 
 
 
 
1C
 
 are distinct,
and that depolarization-induced potentiation may be a
global channel property requiring the participation of
all four homology repeats.
 
MATERIALS AND METHODS
 
Construction of Chimeric and Mutant 
 
 
 
1
 
 cDNAs
 
A and C denote sequence derived from 
 
 
 
1A 
 
(Mori et al., 1991)
or 
 
 
 
1C 
 
(Mikami et al., 1989), respectively.
 
 
 
An asterisk indicates a
restriction site introduced by PCR. The wild-type clones GFP-
 
 
 
1C
 
and GFP-
 
 
 
1A
 
 were produced by fusing the 
 
 
 
1 
 
subunit of either
the cardiac L-type channel (
 
 
 
1C
 
) or neuronal P/Q-type channel
(
 
 
 
1A
 
) at the amino terminus to GFP as previously described
(Grabner et al., 1998). The GFP tag has been shown not to alter
any of the functional properties of the 
 
 
 
1C
 
 and 
 
 
 
1A
 
 subunits
(Grabner et al. 1998). The clone GFP-
 
 
 
1C
 
(TQ
 
→
 
YM) was created
using overlapping PCR mutagenesis (Horton et al., 1989) to re-
place two residues in the IIIS5 transmembrane domain of 
 
 
 
1C
 
(Thr 1066 and Gln 1070), which were previously identiﬁed as
essential components of the DHP binding site (Mitterdorfer et
al., 1996; He et al., 1997), with the corresponding residues of
 
 
 
1A
 
 (Tyr 1393 and Met 1397). In brief, the SalI*-FspI fragment
of 
 
 
 
1C
 
 (nt 
 
 
 
12C–5054C) was subcloned into the SalI and SmaI
sites of the pSP72 (Promega) polylinker. Overlapping PCR us-
ing GFP-
 
 
 
1C
 
 as the template yielded an 816-bp ampliﬁcation
product (nt 2638C–3453C) carrying the point mutations, which
was then cut with AﬂII (nt 2689) and AspI (nt 3385) and ligated
into the AﬂII-AspI restriction sites of the pSP72 subclone. Fi-
nally, the SalI*-EcoRV fragment (nt 
 
 
 
12C–4348C) of the sub-
clone was ligated into GFP-
 
 
 
1C
 
 at the corresponding restriction
sites to yield the clone GFP-
 
 
 
1C
 
(TQ
 
→
 
YM). The 
 
 
 
1C
 
/
 
 
 
1A
 
 chimera
GFP-CACC consisted of repeat II and the I-II linker of 
 
 
 
1A
 
 con-
tained an 
 
 
 
1C
 
 background (amino acids 1–426C/352–671A/
740–2171C). To produce GFP-CACC, the SalI*-EcoRV fragment
of 
 
 
 
1C
 
 (nt 
 
 
 
12C–4348C) was ligated into the corresponding
sites of the plasmid pSP72. PCR mutagenesis was used to am-
plify a 980-bp product of 
 
 
 
1A
 
 sequence, containing the intro-
duced 5
 
 
 
 BamHI* and 3
 
 
 
 EcoRI* restriction sites at nt 1039 and
2015, respectively. The ampliﬁcation product was ﬁrst digested
with BamHI, and then partially digested with EcoRI (to avoid
cutting an internal EcoRI site), and the resulting fragment was
ligated into the corresponding restriction sites of the pSP72/
cardiac subclone. Finally, the SalI*-EcoRV fragment from this
subclone was ligated into the SalI*-EcoRV restriction sites of
GFP-
 
 
 
1C
 
. The chimera GFP-CCAA was composed of repeats I
and II (including the II-III linker) of 
 
 
 
1C
 
 and repeats III and IV
of 
 
 
 
1A
 
 (amino acids 1-920C/1244-2424A). To create GFP-CCAA,
the HindIII*-PvuII fragment (nt 3730A–4216A) of chimera AL2
(Grabner et al., 1996) was coligated with the PvuII-BglII frag-
ment of 
 
 
 
1A
 
 (nt 4216A–5891A) into the corresponding restric-
tion sites of the plasmid pSP72. Subsequently, the XhoI-
HindIII* fragment (nt 1395A–2758C) of clone AL5 (Grabner et
al., 1996) was ligated into the corresponding restriction sites of
the subclone. The entire XhoI-BglII insert (nt 1395A–5891A) of
the ﬁnal subclone was ligated into the corresponding restriction
sites of GFP-
 
 
 
1A
 
 to produce the intermediate clone GFP-ALC.
The SalI*-AvrII fragment (nt 
 
 
 
12C–759C) of GFP-
 
 
 
1C
 
 was coli-
gated with the AvrII-AocI fragment (nt 759C–1752A) of AL5
into the SalI-AocI (5
 
 
 
 polylinker-1752A) restriction sites of GFP-
ALC, yielding the subclone GFP-C/3A. Finally, the ClaI-AﬂII
fragment (nt 256C–2689C) of 
 
 
 
1C 
 
was ligated into the corre-
sponding restriction sites of subclone GFP-C/3A to yield the ﬁ-
nal chimera GFP-CCAA. The integrity of all channel constructs
was conﬁrmed using automated sequence analysis (Macromo-
lecular Resources). 
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Expression and Electrophysiological Analysis of Channels in 
Dysgenic Myotubes
1 wk after plating, primary cultures of mouse dysgenic myotubes
(Adams and Beam, 1989), which lack an endogenous  1S subunit
(Knudson et al., 1989), were microinjected in single nuclei with
cDNAs (200–600 ng/ l) encoding GFP-tagged  1 subunits. 36–
52 h after injection, expressing myotubes were identiﬁed by
green ﬂuorescence and used for electrophysiology. Macroscopic
Ca2  currents were measured using the whole-cell patch-clamp
method (Hamill et al., 1981). Whole-cell patch pipettes of boro-
silicate glass had resistances of 1.5–2.0 M  when ﬁlled with an in-
ternal solution containing 140 mM cesium aspartate, 10 mM
Cs2EGTA, 5 mM MgCl2, and 10 mM HEPES, pH 7.4 with CsOH.
The external bath solution contained 10 mM CaCl2, 145 mM
TEA-Cl, and 10 mM HEPES, pH 7.4 with TEA-OH, plus 3  M tet-
rodotoxin. Test currents were obtained by stepping from a hold-
ing potential of  80 to  30 mV for 1 s (to inactivate endogenous
T-type Ca2  current; Adams et al., 1990), to  50 mV for 30–50
ms, to the test potential for 200 ms, to  50 mV for 125 ms, and
back to  80 mV. Test currents were corrected for linear compo-
nents of leak and capacitative currents by digitally scaling and
subtracting the average of 10 preceding control currents elicited
by hyperpolarizing steps (20–40 mV in amplitude) applied from
Figure 1.  Activation of currents produced by GFP-
 1C or GFP- 1A expressed in dysgenic myotubes. (A)
Representative Ca2  currents elicited by 200-ms depo-
larizing steps to the indicated test potentials from a
holding potential of  80 mV, followed by repolariza-
tion to  50 mV. Putative membrane topology for
each GFP-tagged channel construct is indicated,
where dark gray and light gray represent  1C and  1A
sequence, respectively. (B) Average (  SEM) conduc-
tance versus voltage relationships for GFP- 1C (circles;
n   9) and GFP- 1A (inverted triangles; n   10). The
smooth curves represent best ﬁts of the expression
1/{1   exp [ (V   V1/2)/kG]}, which yielded the fol-
lowing values: for GFP- 1C, V1/2   8 mV, kG   7.3 mV;
and for GFP- 1A, V1/2   19 mV, kG   5.1 mV.498  Distinct Mechanisms of Potentiation
the holding potential. Data were included only for cells in which
the maximum voltage error (calculated by the product of peak
inward current and compensated series resistance) was  10 mV.
Except for tail currents, data were sampled at 1 kHz. Tail cur-
rents, elicited by repolarizing to  50 mV for 125 ms, were re-
corded with fast sampling (10 kHz). Tail-current amplitude (Itail)
was measured 0.5 ms after the onset of the repolarization from
the test pulse to  50 mV. The rate of tail-current decay ( deact)
was measured by ﬁtting tail currents with a single exponential
function. Maximal Ca2  conductance (Gmax) and half-maximal
activation potential (V1/2) were calculated by ﬁtting peak inward
current values with the equation:
(1)
where I is the peak inward Ca2  current measured at the test po-
tential (V), Vrev is the reversal potential, and kG is a slope factor.
The values of Gmax and Vrev were used to calculate normalized
conductance as a function of voltage (see Figs. 1 A and 4 C) ac-
cording to the equation: G (V)   I/[Gmax   (V   Vrev)].
Maximum immobilization-resistant charge movement (Qmax)
was measured, after the addition of 0.5 mM Cd2  and 0.1 mM
La3  to the bath, by integration of Qon for a 15-ms test pulse (ex-
ponentially rounded with a time constant of 100  s) to  40 mV.
Maximum channel Po was calculated from the average, measured
values of   and   according to the equation:
(2)
where       - average dysgenic charge (2.5 nC/ F; Adams
et al., 1990),   is the single-channel conductance in 10 mM Ca2 ,
assumed to be 4 pS for  1A (Adams et al., 1994), 5.8 pS for  1C
(Gollasch et al., 1992), or an average of the two (4.9 pS) for chime-
ras CACC and CCAA, q is the assumed single-channel gating
IG max VV rev – () 1 exp V V12 ⁄ – () – kG ⁄ [] + {} , () ⁄ ⋅ =
Gmax Qmax
Po qG max' F ⋅⋅ () γ Qmax' A ⋅⋅ () ⁄ , =
Qmax' Qmax
charge (9 e ; Noceti et al., 1996), F is Faraday’s constant (96,487
C/mol) and A is Avogadro’s number (6.023   1023 e /mol).
Several different measures were used to quantify potentiation.
For the DHP agonist ( )Bay K 8644, one measure was the ratio
, where the numerator and denominator represent
the peak currents elicited by depolarizing test pulses in the pres-
ence or absence of drug, respectively.   was usually elicited
by a Vtest of approximately  20–30 mV, and   for a Vtest 20–30
mV more hyperpolarized. Agonist-induced potentiation was also
measured by means of the ratios   and  ,
where the tail current was produced by repolarizing to  50 mV
from a Vtest of  40 mV. Depolarization-induced potentiation was
quantiﬁed by the ratios   and  , where the
numerator and denominator were determined from tail currents
produced by repolarization to  50 mV after a Vtest of  90–110
mV or  40 mV, respectively.
Statistical Analysis
Statistical signiﬁcance was assessed using one-way analysis of vari-
ance (ANOVA) and SAS software (version 8). All data are pre-
sented as mean   SEM.
RESULTS
 1C Is Potentiated by DHP Agonist and Strong Depolarization 
while  1A Is Potentiated by Neither
Fig. 1 A illustrates representative whole-cell Ca2  cur-
rents elicited by depolarizing dysgenic myotubes ex-
pressing either GFP- 1C or GFP- 1A to the indicated po-
tentials, followed by repolarization to  50 mV. Based
upon steady-state activation calculated from peak cur-
rents during the test depolarizations (Fig. 1 B), both
channels were fully activated by test pulses to  40 mV
Imax
Bay K Imax
control ⁄
Imax
control
Imax
Bay K
Itail
Bay K Itail
control ⁄ τdeact
Bay K τdeact
control ⁄
Itail
90 + Itail
40 + ⁄ τdeact
90 + τdeact
40 + ⁄
Figure 2. Dihydropyridine agonist potentiates GFP- 1C but not GFP- 1A. (A) Peak Ca2  currents from GFP- 1C (top) or GFP- 1A (bot-
tom) elicited by 200-ms depolarizations to the indicated test potentials in the absence (control) and presence ( Bay K) of 10  M Bay K
8644. (B) Average current versus voltage relationships for GFP- 1C (circles; n   5) and GFP- 1A (inverted triangles; n   7) in the absence
(open symbols) or presence (closed symbols) of 10  M Bay K 8644. The smooth curves represent best ﬁts of Eq. 1 to the average data re-
sulting in the values (control/ Bay K): for GFP- 1C, Gmax   337 nS/nF/620 nS/nF, V1/2   4 mV/ 22 mV, Vrev   93 mV/81 mV, kG   7
mV/2 mV; and for GFP- 1A, Gmax   228 nS/nF/225 nS/nF, V1/2   18 mV/11 mV, Vrev   88 mV/91 mV, kG   7 mV/8 mV.499 Wilkens et al.
and above. Consistent with this, the tail currents for
GFP- 1A had a similar amplitude and time course after
the depolarizations to either  40 or  60 mV (Fig. 1
A). However, for GFP- 1C, the tail current after the
 60-mV depolarization was larger and decayed more
slowly than the tail after the  40-mV step. This behav-
ior is an indication that strong depolarization caused
 1C channels to enter a mode of gating having longer
open times and increased Po.
Fig. 2 compares currents produced by GFP- 1C and
GFP- 1A before and after exposure to 10  M Bay K
8644. For GFP- 1A, application of Bay K 8644 had little
effect on either the current elicited by a test depolariza-
tion to  20 mV or on the tail current after repolariza-
tion (Fig. 2 A). Likewise, the average, peak current ver-
sus voltage relationship for GFP- 1A was not signiﬁcantly
(P   0.1) affected by the agonist (Fig. 2 B). By contrast,
Bay K 8644 caused a hyperpolarizing shift in the test po-
tential evoking maximum inward current for GFP- 1C,
together with a substantial increase in the magnitude of
this current. In addition to affecting the peak current,
Bay K 8644 also caused an approximately threefold in-
crease in tail-current amplitude (Itail) and in the time
constant of tail-current deactivation ( deact) for GFP- 1C
(Fig. 2 A and Table I). Overall, the effects of Bay K 8644
on GFP- 1C tail currents qualitatively resemble those of
strong depolarization (compare Figs. 1 A and 2 A).
Fig. 3 illustrates a more detailed characterization of
tail currents in cells expressing GFP- 1C or GFP- 1A.
Fig. 3 A shows the standard protocol for quantifying de-
polarization-induced potentiation, which was deter-
mined as the ratio of either Itail or  deact for a tail current
after a Vtest of  90 mV, to the corresponding values for
a tail current after a Vtest of  40 mV. By both measures,
GFP- 1C showed substantial depolarization-induced po-
tentiation, whereas GFP- 1A did not (Fig. 3 A and Table
I). Fig. 3 B illustrates the dependence of Itail on prior
test potentials ranging from  40 to  80 mV. For GFP-
 1A, Itail reached a maximum after a Vtest of  30 mV, in
good agreement with the conductance versus voltage
curve calculated from peak currents (Fig. 1 B). For still
stronger depolarizations, Itail became smaller for GFP-
 1A, as expected for a channel undergoing voltage-
dependent inactivation that becomes faster with stronger
depolarization. In contrast to GFP- 1A, Itail for GFP-
 1C increased monotonically over the entire range of
test potentials. This monotonic increase differs from
the saturating conductance versus voltage relationship
(Fig. 1 B) and is consistent with entry into a potenti-
ated state having high Po. This monotonic voltage de-
pendence also suggests that depolarization-induced po-
tentiation is not dependent upon Ca2  entry during
the prepulse. The application of 10  M Bay K 8644
caused a still further increase in Po, which is indicated
by a substantial increase in Itail for GFP- 1C at any given
test potential (Fig. 3 B). In the presence of agonist, Itail
was still increased by stronger test depolarizations, up
to at least  70 mV. Table I summarizes the effects of
DHP agonist and strong depolarization on tail currents
for GFP- 1C and GFP- 1A.
Mutation of T1066 and Q1070 of  1C Eliminates Agonist- 
but Not Depolarization-induced Potentiation
The observation that GFP- 1C is potentiated by both
agonist and strong depolarization, whereas GFP- 1A
is potentiated by neither, raises the possibility that
agonist- and depolarization-induced potentiation are
linked. As one test of this hypothesis, we created GFP-
TABLE I
Parameters of DHP Agonist- and Depolarization-induced Potentiation
GFP- 1C GFP- 1C(TQ→YM) GFP-CACC GFP-CCAA GFP- 1A 
Depolarization-induced 
potentiation of Itail
1.9-fold   0.3
(8)
2.5-fold   0.3
(11)
1.3-fold   0.1
(8)
1.1-fold   0.3
(7)
0.9-fold   0.1
(8)
Depolarization-induced 
potentiation of  deact 
2.6-fold   0.8
(5)
2.7-fold   0.3
(8)
1.2-fold   0.1
(8)
1.0-fold   0.1
(7)
0.9-fold   0.1
(6)
Bay K-induced 
potentiation of Imax
2.7-fold   0.2
(5)
0.9-fold   0.1
(7)
3.4-fold   0.9
(5)
1.0-fold   0.1
(9)
1.1-fold   0.1
(7)
Bay K-induced activation
shift (V1/2; mV)
 24.9   4.1
(5)
 3.3   4.2
(6)
 15.7   5.4
(5)
 3.0   0.9
(9)
 3.9   1.2
(6)
Bay K-induced 
potentiation of Itail
3.3-fold   0.6
(5)
0.9-fold   0.1
(7)
6.2-fold   3.7
(5)
1.3-fold   0.4
(9)
1.2-fold   0.1
(6)
Bay K-induced
potentiation of  deact
2.9-fold   0.5
(5)
1.2-fold   0.1
(7)
3.0-fold   0.9
(5)
1.1-fold   0.1
(9)
1.2-fold   0.1
(6)
Itail and  deact were determined as the amplitude (0.5 ms after repolarization) and time constant of decay (determined by fit of a single exponential) of tail
currents produced by repolarization to  50 mV. Depolarization-induced potentiation was quantified as the ratios ( ) or ( ),
where the superscripts indicate the test potential before repolarization. The effect of 10  M Bay K 8644 was quantified in terms of four parameters: the
ratio of maximum currents ( ); the average shift in the voltage for half-maximal activation ( ); and the ratio of the values of
Itail ( ) and  deact ( ) after a test to  40 mV. All data are presented as mean   SEM, with the numbers in parentheses indicating
the number of cells tested.
Itail
90 + Itail
40 + ⁄ () τdeact
90 + τdeact
40 + ⁄
Imax
Bay K Imax
control ⁄ V12 ⁄
Bay K V12 ⁄
control –
Itail
Bay K Itail
control ⁄ τdeact
Bay K τdeact
control ⁄500  Distinct Mechanisms of Potentiation
 1C(TQ→YM), in which two residues of IIIS5 that are
critical for the DHP sensitivity of  1C (Mitterdorfer et
al., 1996; He et al., 1997) were converted to the corre-
sponding residues of  1A. Currents produced by GFP-
 1C(TQ→YM) were not affected by the addition of 10
 M Bay K 8644 (Fig. 4 A), whereas depolarization-
induced potentiation was intact (Fig. 4 B). In particu-
lar, tail currents were larger and decayed more slowly
after a Vtest of  90 mV compared with a Vtest of  40
mV (Fig. 4 B, top) and the tail-current amplitude in-
creased monotonically as a function of test potential
(Fig. 4 B, bottom). On average, GFP- 1C(TQ→YM) was
quantitatively similar to GFP- 1C with respect to depo-
larization-induced potentiation, but was indistinguish-
able from GFP- 1A in the lack of agonist-induced po-
tentiation (Table I). Interestingly, mutation of T1066
and Q1070 in the IIIS5 transmembrane segment of  1C
resulted in a decreased steepness, and positive shift, of
the steady-state activation curve in comparison to GFP-
 1C (Fig. 4 C), indicating that these residues can affect
activation gating. Taken together, the data of Fig. 4
demonstrate that depolarization-induced potentiation
still occurs in a mutant  1C lacking a response to DHP
agonist.
Agonist-induced Potentiation Persists in the Absence of 
Depolarization-induced Potentiation
In an attempt to determine whether a single repeat of
 1C is sufﬁcient to allow depolarization-induced poten-
tiation, we constructed the chimeras GFP-CACC and
GFP-CCAA and tested them for agonist- and depolar-
ization-induced potentiation (Fig. 5). GFP-CACC con-
sists of repeat II and the I-II linker of  1A in an other-
wise  1C background (Fig. 5, A and C), and thus con-
tains an intact DHP agonist binding site (Grabner et
al., 1996; Hockerman et al., 1997; Ito et al., 1997; Sin-
negger et al., 1997). As shown in Fig. 5 A, 10  M Bay K
8644 potentiated maximum inward current in cells ex-
pressing GFP-CACC and caused a leftward shift in the
peak current versus voltage relationship. Quantitatively,
both effects were similar to those of 10  M Bay K 8644
on GFP- 1C (Table I). However, this chimera failed to
show the large depolarization-induced potentiation
characteristic of either GFP- 1C or GFP- 1C(TQ→YM)
(Table I; also, compare Fig. 5 C with Figs. 3 B and 4 B).
Thus agonist-induced potentiation can be present in a
channel construct that lacks signiﬁcant depolarization-
induced potentiation. The chimera GFP-CCAA (Fig. 5,
B and D) consists of the ﬁrst two repeats and the II-III
Figure 3. Depolarization-induced potentiation of GFP- 1C but not of GFP- 1A. (A) Tail currents were elicited by depolarization from the
holding potential ( 80 mV) to  30 mV for 1 s (to inactivate endogenous T-type current; Adams et al., 1990), a 30–50-ms repolarization to
 50 mV, a 200-ms test depolarization (Vtest) to varying potentials, followed by repolarization to  50 mV. Whole-cell currents are shown for
GFP- 1C (top) and GFP- 1A (bottom) for test depolarizations of  40 and  90 mV. Note that for GFP- 1C, the tail current after the Vtest of
 90 mV was larger and decayed more slowly than that after the Vtest of  40 mV, whereas the tail currents for GFP- 1A differed little for a
Vtest of  40 or  90 mV. The 50-ms time calibration applies to the currents during the test depolarization and the 5-ms calibration to the
tail currents at  50 mV. (B) Relationship of tail-current amplitude (Itail) at  50 mV to test pulse potential (Vtest) for cells expressing GFP-
 1C (circles; n   5) or GFP- 1A (inverted triangles; n   7) in the absence (open symbols) or presence (closed symbols) of 10  M Bay K
8644. The amplitude of the tail currents for GFP- 1C grew larger with increasing Vtest over the entire range of potentials examined, whereas
those for GFP- 1A appeared to saturate with peak current.501 Wilkens et al.
linker of  1C fused to repeats III and IV of  1A. GFP-
CCAA lacked both agonist- and depolarization-induced
potentiation (Fig. 5, B and D, and Table I). Fig. 6 sum-
marizes the effects of strong depolarization and DHP
agonist on the constructs GFP- 1C, GFP- 1C(TQ→YM),
GFP-CACC, and GFP- 1A. The asterisks indicate a sig-
niﬁcant (P    0.05) difference from onefold (where
onefold indicates a lack of potentiation). Fig. 6 demon-
strates that depolarization-induced potentiation can
persist in the absence of potentiation by agonist (i.e.,
Figure 4. Mutation of the agonist binding site of GFP- 1C abolishes potentiation by agonist (A) but not by depolarization (B). (A, top)
Whole-cell currents from a myotube expressing GFP- 1C(TQ→YM) in the absence (control) or presence ( Bay K) of 10  M Bay K 8644.
(A, bottom) Average peak current versus voltage relationship for GFP- 1C(TQ→YM) in the absence (open squares; n   7) or presence
(closed squares; n   7) of 10  M Bay K 8644. The smooth curves represent best ﬁts of the data with Eq. 1, yielding the values (control/
 Bay K): Gmax   287 nS/nF/218 nS/nF, V1/2   9 mV/1 mV, Vrev   103 mV/104 mV, kG   10 mV/13 mV. (B, top) Whole-cell currents for
GFP- 1C(TQ→YM) measured for test pulses to  40 or  90 mV, followed by repolarization to  50 mV; for clarity, the tail currents at  50
mV are shown on a faster time scale (5-ms calibration bar). (B, bottom) Tail-current amplitudes at  50 mV as a function of a prior test po-
tential for GFP- 1C(TQ→YM) (open squares; n   11). (C) Conductance versus voltage relationships for GFP- 1C (circles; n   9) and GFP-
 1C(TQ→YM) (squares; n   10). The smooth lines represent best ﬁts of the data with the expression: 1/{1   exp [ (V   V1/2)/kG]}, yield-
ing the following values: for GFP- 1C, V1/2   9 mV, kG   7 mV; and for GFP- 1C(TQ→YM), V1/2   20 mV, kG   16 mV.502  Distinct Mechanisms of Potentiation
GFP- 1C(TQ→YM)), and potentiation by agonist can
occur in the absence of depolarization-induced poten-
tiation (i.e., GFP-CACC); therefore, the two processes
likely occur via distinct mechanisms.
No Single Repeat of  1C Is Sufﬁcient for
Depolarization-induced Potentiation
Fig. 7 shows that in terms of both amplitude of tail cur-
rents (A) and  deact (B), the chimeras GFP-CACC and
GFP-CCAA, like  1A, lacked depolarization-induced po-
tentiation. Because GFP-CACC lacked depolarization-
induced potentiation, none of the three cardiac re-
peats contained in this construct (i.e., I, III, and IV)
appears to be sufﬁcient, individually or in concert, to
mediate this process. In addition, because GFP-CCAA
contains a cardiac repeat II and lacked depolarization-
induced potentiation, a cardiac repeat II does not ap-
pear to be sufﬁcient, either alone or in combination
with repeat I. In conclusion, no single repeat of  1C
seems to be sufﬁcient for depolarization-induced po-
tentiation, which may instead represent a more global
property. Several combinations of multiple repeats are
Figure 5. Presence or absence of potentiation by agonist or depolarization for chimeric channels. The chimeric channels GFP-CACC
and GFP-CCAA are represented schematically with dark gray and light gray representing regions derived from  1C and  1A, respectively. (A
and B) Average peak current versus voltage relationships for cells expressing GFP-CACC (diamonds; n   5) or GFP-CCAA (triangles; n  
7), in the absence (open symbols) or presence (closed symbols) of 10  M Bay K 8644. The smooth lines represent best ﬁts of Eq. 1 to the
average data, yielding the following values (control/ Bay K): for GFP-CACC, Gmax   111 nS/nF/283 nS/nF, V1/2   0 mV/ 14 mV, Vrev  
86 mV/73 mV, kG   6 mV/5 mV; and for GFP-CCAA, Gmax   142 nS/nF/133 nS/nF, V1/2   17 mV/15 mV, Vrev   84 mV/86 mV, kG   4
mV/7 mV. (C and D) Average values of tail-current amplitudes as a function of test potential for cells expressing GFP-CACC (open dia-
monds; n   8) or GFP-CCAA (open triangles; n   7). Insets illustrate superimposed currents elicited by test depolarizations to  90 or  40
mV, with the horizontal scale bars corresponding to 5 ms for the tail currents and 50 ms during the test depolarization. The vertical scale
bars correspond to either 5 pA/pF (C) or 1 pA/pF (D). GFP-CACC was potentiated by agonist but not depolarization, whereas GFP-CCAA
was potentiated by neither.503 Wilkens et al.
tested by the chimeras examined in this paper, and oth-
ers cannot be tested because not all possible combina-
tions of repeats of L-type and non–L-type sequence
produce functional channels (Grabner et al., 1996;
Spaetgens and Zamponi, 1999).
Because potentiation is deﬁned by a shift into a gat-
ing mode of substantially increased Po, it seems likely
that potentiation could not occur in a channel already
having a relatively high Po. Therefore, it is of interest to
know whether the lack of depolarization-induced po-
tentiation in GFP-CACC and GFP-CCAA is a conse-
quence of an already high Po. We used Eq. 2 (materi-
als and methods) to estimate Po for GFP- 1C, GFP-
CACC, GFP-CCAA, and GFP- 1A from measured values
of Gmax and Qmax. The values estimated by this ap-
proach for both GFP- 1C and GFP- 1A (Table II) are in
reasonable agreement with values determined from sin-
gle-channel measurements for  1C ( 0.05; Cachelin et
al., 1983; Lew et al., 1991) or  1A (0.6; Llinas et al.,
1989). Moreover, as shown in Fig. 7 C, the estimated Po
for GFP- 1A was about 30-fold higher than for GFP- 1C.
The estimated Po for GFP-CCAA was similar to that of
GFP- 1A, but estimated Po for GFP-CACC was much
closer to that of GFP- 1C (Fig. 7 C and Table II). The
absence of depolarization-induced potentiation for
GFP-CACC indicates that a low Po alone is not a sufﬁ-
cient condition for this process to occur. The lack of
depolarization-induced potentiation for GFP-CACC is
even more striking given that this construct can be
strongly potentiated by agonist.
DISCUSSION
In the present study, we have examined DHP- and de-
polarization-induced potentiation of L-type Ca2  chan-
nels by expressing GFP-tagged cardiac ( 1C) and neu-
ronal ( 1A)  1 subunits in dysgenic myotubes. For GFP-
 1C, both strong depolarization and agonist (10  M Bay
K 8644) caused tail currents to become larger and to
decay more slowly, whereas tail currents for GFP- 1A
were not affected by either manipulation. Introduction
of two point mutations (T1066Y and Q1070M) into
GFP- 1C abolished potentiation by agonist without any
evident effect on potentiation by depolarization. Con-
versely, agonist but not depolarization caused potentia-
tion of a chimera of  1C and  1A (GFP-CACC). Because
depolarization-induced potentiation was absent for
both GFP-CACC and the chimera GFP-CCAA, it ap-
pears that no single repeat of  1C can be responsible for
this process. GFP-CACC displayed a relatively low esti-
mated Po, quite similar to that of GFP- 1C, whereas the
estimated Po for both GFP-CCAA and GFP- 1A  was
much higher. Therefore, a channel that displays a low
Po (and is potentiated by agonist) can fail to be potenti-
ated by depolarization.
Independent Pathways for Potentiation by DHP 
Agonist and Depolarization
Unitary records of L-type Ca2  channels have been de-
scribed as having three modes of gating upon depolar-
ization: mode 0 (null sweeps); mode 1 characterized by
brief openings ( 1 ms) in bursts; and mode 2 deﬁned
by longer openings and high Po (Hess et al., 1984).
Mode 1 is the predominant mode accessed during
moderate depolarizations from the holding potential
in the absence of DHP agonist, whereas mode 2 is pro-
moted by the presence of agonist (Hess et al., 1984).
Strong depolarization also promotes long openings of
L-type channels in both chromafﬁn (Hoshi and Smith,
1987) and cardiac cells (Pietrobon and Hess, 1990). Be-
cause we have found that potentiation by either agonist
or depolarization can be eliminated without a quantita-
tive reduction in the effect of the other, it appears that
these two processes occur via distinct pathways. In addi-
tion, we have used a concentration of agonist (10  M
Bay K 8644) that is supramaximal (Kokubun and Reu-
Figure 6. Agonist- and de-
polarization-induced potenti-
ation occur via distinct mech-
anisms. (A) Average potentia-
tion of tail-current amplitude
by strong depolarization
( , white bars) or
10   M Bay K 8644
( , hatched bars)
for the indicated constructs
expressed in dysgenic myo-
tubes. (B) Average potentia-
tion of  deact by strong depo-
larization ( , white
bars) or 10  M Bay K 8644
( , hatched bars)
for the indicated constructs
Itail
90 + Itail
40 + ⁄
Itail
Bay K Itail
control ⁄
τdeact
90 + τdeact
40 + ⁄
τdeact
Bay K τdeact
control ⁄
expressed in dysgenic myotubes. The dashed lines at onefold indicate no potentiation. Asterisks indicate a signiﬁcant difference (P  
0.05) from 1. The number of cells tested in each group ranged from ﬁve to eight.504  Distinct Mechanisms of Potentiation
ter, 1984); therefore, the additional potentiation of tail
currents by depolarization in the presence of the ago-
nist also strongly suggests the presence of two indepen-
dent pathways leading to a potentiated open state. Sev-
eral other labs have likewise concluded from the addi-
tivity of the effects of depolarization and agonist, that
these two stimuli cause an increased Po by distinct path-
ways (Bourinet et al., 1994; Parri and Lansman, 1996).
Moreover, single-channel measurements show both dif-
ferent open times and ﬁrst latencies depending on
whether potentiation is induced by depolarization or
agonist (Hoshi and Smith, 1987). In combination,
these data suggest not only that mode 2 gating can be
accessed by multiple pathways, but also that mode 2
consists of more than one potentiated open state.
Bay K 8644 is well-known to shift activation in the hy-
perpolarizing direction (Fig. 2; Hess et al., 1984; San-
guinetti et al., 1986), indicating that it shifts equilib-
rium towards the open state of the channel. We have
shown here that mutation of residues T1066 and Q1070
in the IIIS5 transmembrane domain of  1C not only ab-
lates the response to agonist, but also shifts the voltage
dependence of activation oppositely, in the depolariz-
ing direction. On this basis, one could hypothesize that
Bay K 8644 promotes a conformation of these two resi-
Figure 7. Depolarization-induced potentiation cannot be local-
ized to any single channel repeat. Average depolarization-induced
potentiation of tail-current amplitude (A), or tail-current deactiva-
tion (B) for the indicated constructs. Channel open probability
(Po) for the same constructs (C) was estimated according to Eq. 2
(as described in materials and methods). Values for Po were as
follows:  1C   0.01, CACC   0.03, CCAA   0.14, and  1A   0.21.
The dashed lines at onefold indicate no potentiation. The num-
ber of cells tested in each group ranged from ﬁve to eight. Aster-
isks indicate a signiﬁcant difference (P   0.05) from 1.
TABLE II
Properties of Wild-type and Chimeric Channels Expressed 
in Dysgenic Myotubes
Units GFP- 1C  GFP-CACC GFP-CCAA GFP- 1A
Imax  pA/pF 35.2   4.1
(19)
 7.0   1.1
(16)
4.8   1.1
(18)
22.3   4.8
(16)
V1/2  mV  6.0   0.6
(10)
 7.6   2.2
(16)
 15.3   1.5
(17)
 18.1   1.7
(12)
Gmax nS/nF 436.4    76.1
(13)
118.5   13.8
(16)
105.0   20.7
(18)
352.0   61.9
(16)
Qmax nC/ F 20.9   2.7
(6)
3.0   0.5
(11)
2.9   0.4
(10)
3.2   0.3
(7)
Po  0.007
(5)
0.028
(6)
0.144
(6)
0.212
(7)
Imax is the peak inward current determined by measuring Ca2  currents
elicited with 200-ms test depolarizations ranging from  40 to  100 mV.
Values for half-maximal activation potential (V1/2) and maximal
conductance (Gmax) were determined by fitting peak Ca2  currents
according to Eq. 1. Maximum immobilization-resistant charge movement
(Qmax) was measured by integration of the “On” gating current for a 15-ms
step to  40 mV. Open channel probability (Po) was estimated using Eq. 2
and measured values of   and   (as described in materials and
methods). All data are presented as mean    SEM, with numbers in
parentheses indicating the number of cells tested.
Gmax Qmax505 Wilkens et al.
dues that stabilizes open states of the channel, and mu-
tation of these residues destabilizes this conformation.
Role of Accessory Subunits and of Phosphorylation in 
Depolarization-induced Potentiation
The accessory   subunit has been shown to inﬂuence
modal gating of  1C. In particular, comparison of  1C ex-
pressed with or without the  2a subunit showed that  2a
increased both open times and the proportion of long
openings (Costantin et al., 1998).   subunits also have
been reported to affect depolarization-induced facilita-
tion, which may be mechanistically related to depolar-
ization-induced potentiation (introduction). Speciﬁ-
cally, depolarization-induced facilitation was found to
occur when  1C was coexpressed with the  1,  3, or  4
subunits (Bourinet et al., 1994; Cens et al., 1998), but
not with  2a (Cens et al., 1996), raising the possibility
that the   subunit plays a direct role in depolarization-
induced facilitation of  1C, and perhaps in potentiation
as well. However, others have found that depolarization-
induced potentiation of the smooth muscle  1C occurs
in the absence of any   subunit (Kleppisch et al., 1994).
Whatever the exact role of the   subunit, our results
demonstrate that depolarization-induced potentiation
is strongly inﬂuenced by the  1 subunit itself, because all
of the  1 constructs examined in this study have a con-
served “alpha interaction domain” (site of   subunit
binding; Pragnell et al., 1994) and were expressed with
a common   subunit ( 1a, which is endogenous to skele-
tal muscle; Ruth et al., 1989).
Evidence has been presented that PKA-dependent
phosphorylation occurring during depolarizing pre-
pulses is necessary for depolarization-induced facilita-
tion of  1S (Sculptoreanu et al., 1993b; Johnson et al.,
1994), the cardiac  1C (Sculptoreanu et al., 1993a), and
the neuronal  1C (Sculptoreanu et al., 1995). Evidence
also has been presented that phosphorylation dur-
ing depolarization is not involved in depolarization-
induced facilitation of the neuronal  1C, although basal
phosphorylation may be required (Bourinet et al.,
1994). If phosphorylation is required (either basal or
voltage-dependent), then it seems unlikely to involve
phosphorylation of  1C directly because truncation of
the consensus PKA sites (Gao et al., 1997) of the  1C
carboxyl tail does not eliminate depolarization-induced
facilitation (Cens et al., 1998). Consistent with this re-
sult, we found that depolarization-induced potentia-
tion does not occur for GFP-CACC even though it con-
tains all the consensus PKA sites of  1C.
Structural Determinants of Depolarization-induced 
Potentiation and Low Po
As discussed above, brief openings predominate during
activation of  1C by modest depolarizations applied
from a negative holding potential (mode 1 gating).
The conformational changes responsible for activation
of these brief openings occur rapidly (macroscopic ac-
tivation occurs with a time constant of several ms at
 30 mV; Tanabe et al., 1991). Depolarization-induced
entry into mode 2 occurs on a signiﬁcantly slower time
scale (with a time constant of several hundred ms at
 30 mV) and over a much more positive voltage range
(Pietrobon and Hess, 1990). Despite these differences,
depolarization-induced potentiation resembles mode 1
activation in being strongly voltage-dependent: based
on two-state Boltzmann ﬁts, the effective gating charge
is 2.5 for depolarization-induced potentiation and 3.2
for mode 1 activation (Pietrobon and Hess, 1990).
Thus, the question arises as to the identity of the volt-
age sensor for depolarization-induced potentiation.
One possibility is that, after undergoing the relatively
rapid movements leading to mode 1 openings, the S4
segments can undergo subsequent, slower movements
in response to still stronger depolarization. It is equally
possible that structures other than S4 serve as voltage
sensors for depolarization-induced potentiation. Be-
cause we found that neither GFP-CACC nor GFP-CCAA
undergo depolarization-induced potentiation, it seems
unlikely that the voltage-sensing structures for depolar-
ization-induced potentiation are localized within a sin-
gle repeat. Rather, depolarization-induced potentiation
of  1C appears to require large movements of charge
distributed throughout the protein.
L-type channels like  1S and  1C differ from  1A chan-
nels in that the L-type channels display agonist- and de-
polarization-induced potentiation, and also have a much
lower Po, raising the possibility that the structural deter-
minants of potentiation and low Po reside in similar
structures. However, the chimera GFP-CACC had a rela-
tively low Po, yet did not display signiﬁcant depolariza-
tion-induced potentiation. Because the chimera GFP-
CCAA displayed a high Po, the amino-terminal half of  1C
(repeats I and II) does not appear to be an important de-
terminant of low Po; instead, structural requirements for
low Po may reside in the carboxyl half of the protein. Cer-
tainly, it is attractive to hypothesize that repeats III and IV
are important for the intrinsic, low Po of L-type channels
since these same two repeats play an essential role in ago-
nist binding, which increases Po. A role for the carboxyl
tail in determining Po is suggested by previous work
showing that Po of  1C is markedly increased by partial
truncation of the carboxyl tail (Wei et al., 1994).
As stated earlier, the Po of the L-type channels con-
taining   1C (  0.05; Cachelin et al., 1983; Lew et al.,
1991) is much lower than that of the neuronal channels
containing  1A (0.6; Llinas et al., 1989) or  1B (0.5; Del-
cour and Tsien, 1993). Because single-channel conduc-
tance varies less than twofold amongst these channels
([ 1C] Kokobun and Reuter, 1984; [ 1A] Zhang et al.,
1993; [ 1B] Rittenhouse and Hess, 1994), the produc-506  Distinct Mechanisms of Potentiation
tion of an equivalent macroscopic current would re-
quire a much higher density of the L-type channels. A
primary role of L-type Ca2  channels in muscle is to reg-
ulate Ca2  movements through ryanodine receptors.
For this control to be relatively tight, it may be useful to
have an  1:1 correspondence between the plasmalem-
mal L-type channels and the intracellular ryanodine re-
ceptors. Perhaps this correspondence is best served by a
relatively high density of low Po channels. Conversely, a
high Po and relatively low channel density would be ad-
vantageous when it is critical that a cellular response be
triggered by the activation of only a few channels. Im-
portant goals for future work will be to better deﬁne the
structures determining the differences in Po between
 1C and neuronal channels like  1A and  1B, and to iden-
tify the conformational rearrangements that occur dur-
ing potentiation of L-type channels.
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